FDA Approves Gilead Drug To Prevent HIV

Law360, New York (July 16, 2012, 7:00 PM EDT) -- For the first time ever, the U.S. Food and Drug Administration has approved a drug to prevent the sexual transmission of HIV, an approval officials said Monday would help the government meet its goal of reducing new HIV diagnoses by 25 percent in the next three years.

The drug, Truvada by Gilead Sciences Inc., has been approved since 2004 to treat adults and children with HIV. But the new use approved by the FDA will allow HIV-negative adults who have a high risk of contracting the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.